CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Mensinger Mike Chief Product Officer | Sale | −1,064 | $12.36 | $13K | 188,793 |
| 2026-03-02 | Hopman Mark Chief Commercial Officer | Sale | −834 | $12.36 | $10K | 139,486 |
| 2026-02-27 | Russell Steven Jon Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +91,520 | 91,520 | ||
| 2026-02-27 | Saint Sean President & CEO | Grant or award · Employee Stock Option (right to buy) | +287,944 | 287,944 | ||
| 2026-02-27 | Feider Stephen Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +110,342 | 110,342 | ||
| 2026-02-27 | Mensinger Mike Chief Product Officer | Grant or award · Employee Stock Option (right to buy) | +91,520 | 91,520 | ||
| 2026-02-27 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +91,520 | 91,520 | ||
| 2026-02-27 | Russell Steven Jon Chief Medical Officer | Grant or award | +109,105 | 180,122 | ||
| 2026-02-27 | Russell Steven Jon Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +58,749 | 58,749 | ||
| 2026-02-27 | Saint Sean President & CEO | Grant or award | +343,269 | 441,193 | ||
| 2026-02-27 | Saint Sean President & CEO | Grant or award · Employee Stock Option (right to buy) | +184,837 | 184,837 | ||
| 2026-02-27 | Feider Stephen Chief Financial Officer | Grant or award | +131,543 | 174,157 | ||
| 2026-02-27 | Feider Stephen Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +70,831 | 70,831 | ||
| 2026-02-27 | Mensinger Mike Chief Product Officer | Grant or award | +109,105 | 189,857 | ||
| 2026-02-27 | Mensinger Mike Chief Product Officer | Grant or award · Employee Stock Option (right to buy) | +58,749 | 58,749 | ||
| 2026-02-27 | Hopman Mark Chief Commercial Officer | Grant or award | +109,105 | 140,320 | ||
| 2026-02-27 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +58,749 | 58,749 | ||
| 2026-01-13 | Jones Christy Director | Grant or award | +3,997 | 15,244 | ||
| 2026-01-13 | Lezack Adam Director | Grant or award | +3,997 | 12,432 | ||
| 2026-01-13 | Palasis Maria Director | Grant or award | +3,997 | 12,432 |
Page 4 of 11 · 210 trades